Hepapar (Apotheca Company)


Welcome to the PulseAid listing for the Hepapar drug offered from Apotheca Company. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Apotheca Company
NON-PROPRIETARY NAME: Carduus marianus, Chelidonium majus, Taraxacum officinale
SUBSTANCE NAME: SILYBUM MARIANUM SEED; CHELIDONIUM MAJUS; TARAXACUM OFFICINALE; CHENOPODIUM AMBROSIOIDES; PORK LIVER; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; PHOSPHO
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2010-05-21
END MARKETING DATE: 0000-00-00


Hepapar HUMAN OTC DRUG Details:

Item DescriptionHepapar from Apotheca Company
LABELER NAME: Apotheca Company
DEA SCHEDULE:
ACTIVE STRENGTH: 3; 3; 3; 6; 6; 12; 12; 12; 12; 12([hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL)
START MARKETING DATE: 2010-05-21
END MARKETING DATE: 0000-00-00
PRODUCT ID: 57520-0413_bf47ad4a-c1a8-4ff8-a1f7-5ff5308c5018
PRODUCT NDC: 57520-0413
APPLICATION NUMBER:

Other SILYBUM MARIANUM SEED; CHELIDONIUM MAJUS; TARAXACUM OFFICINALE; CHENOPODIUM AMBROSIOIDES; PORK LIVER; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; PHOSPHO Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Apotheca CompanyHepapar